| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $138.6M | +32.3% |
| Cost of Revenue | $38.0M | +71.3% |
| R&D Expense | $80.1M | +43.2% |
| SG&A Expense | $52.2M | +5.8% |
| Operating Income | -$34.9M | -53.7% |
| Pre-tax Income | -$33.3M | -58.0% |
| Income Tax | $276K | +46.0% |
| Net Income | -$33.6M | -57.9% |
| EPS (Basic) | -$0.51 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $114.0M | -2.4% |
| Accounts Receivable | $31.9M | +27.9% |
| Inventory | $2.0M | +74.9% |
| Current Assets | $162.9M | +0.6% |
| Total Assets | $250.4M | +1.6% |
| Current Liabilities | $49.1M | +47.0% |
| Total Liabilities | $105.6M | +28.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.3M | +179.1% |
| Capital Expenditures | $8.3M | -39.9% |
| Investing Cash Flow | -$13.6M | +36.6% |
| Financing Cash Flow | -$575K | -115.3% |
| Free Cash Flow | $3.0M | +110.6% |
| -54.5% |
| EPS (Diluted) | -$0.51 | -54.5% |
| Stockholders' Equity |
| $144.8M |
| -11.9% |